Core players and where they stand
The Council’s stand is clear. It only approves B.Pharm, D.Pharma and Pharma.D programmes. No other programme is valid.
Individual universities hide behind the UGC Act which empowers them to award any academic degree and hence argue that all their degrees are valid.
This is a classic case of a profession not keeping up with academia. The profession is not interested in investing time and energy in evaluating whether the alternative or new programmes that are on offer in a host of institutions provide the students with competencies essential to practice the profession or teach the same.
The case is not limited to NIPER. Many deemed universities too offer Master’s programme, which are not approved by PCI. But despite their courses having tremendous market value, despite the students finding plum positions in various pharma companies the profession fails to take note and take steps to approve them as professional courses.
For no fault of the student, he or she is now saddled with a degree from a premier academic institutions, but cannot aspire to become an academic or a professional? What can be more cruel?
Click the image (on the right) to view PCI website which announces that MS programmes are unapproved
Do you have a query on this issue? Careers360 will answer your queries through the month of September. Post your queries today!